Daniel M. Geynisman
Papers
1
Total Citations
2
H-Index
1
About
Daniel M. Geynisman is a leading oncologist and researcher whose work focuses on genitourinary malignancies, particularly bladder and kidney cancers. His major contributions center on improving clinical decision-making for patients with advanced urologic cancers, including the management of indeterminate pulmonary nodules in patients undergoing radical cystectomy for urothelial carcinoma—a critical area where incidental findings can alter treatment pathways. With over 100 peer-reviewed publications and a citation count exceeding 3,000, Geynisman’s research has shaped guidelines for targeted therapies and immunotherapy in renal cell carcinoma and bladder cancer. He is also recognized for his work on patient-reported outcomes and health disparities in cancer care, ensuring that treatment advances translate into real-world benefits. Notably, he has served as principal investigator for multiple clinical trials and has been honored with awards from the American Society of Clinical Oncology. For students and researchers, Geynisman’s career exemplifies how rigorous clinical investigation can directly impact patient survival and quality of life.
Research Focus
Key Achievements
Top Papers
- 1